Global Artemisinine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Artemisinine market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinine is forecast to a readjusted size of US$ 77 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Artemisinine market. Artemisinine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artemisinine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artemisinine market.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Key Features:
The report on Artemisinine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artemisinine market. It may include historical data, market segmentation by Type (e.g., Extraction from Artemisia annua, Semisynthetic Artemisinine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artemisinine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artemisinine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artemisinine industry. This include advancements in Artemisinine technology, Artemisinine new entrants, Artemisinine new investment, and other innovations that are shaping the future of Artemisinine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artemisinine market. It includes factors influencing customer ' purchasing decisions, preferences for Artemisinine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artemisinine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artemisinine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artemisinine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artemisinine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artemisinine market.
Market Segmentation:
Artemisinine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Artemisinine market?
What factors are driving Artemisinine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinine market opportunities vary by end market size?
How does Artemisinine break out type, application?
According to our LPI (LP Information) latest study, the global Artemisinine market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinine is forecast to a readjusted size of US$ 77 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Artemisinine market. Artemisinine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artemisinine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artemisinine market.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Key Features:
The report on Artemisinine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artemisinine market. It may include historical data, market segmentation by Type (e.g., Extraction from Artemisia annua, Semisynthetic Artemisinine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artemisinine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artemisinine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artemisinine industry. This include advancements in Artemisinine technology, Artemisinine new entrants, Artemisinine new investment, and other innovations that are shaping the future of Artemisinine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artemisinine market. It includes factors influencing customer ' purchasing decisions, preferences for Artemisinine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artemisinine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artemisinine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artemisinine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artemisinine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artemisinine market.
Market Segmentation:
Artemisinine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Extraction from Artemisia annua
- Semisynthetic Artemisinine
- Injections
- Tablets
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Guilin Pharmaceutical
- CAT KHANH
- Novanat Bioresource
- BEEPZ
- KPC Pharmaceuticals
- BIONEXX
- Guangxi xiancaotang
- Sanofi
- Natural Bio-engineering
- Kerui nanhai
What is the 10-year outlook for the global Artemisinine market?
What factors are driving Artemisinine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artemisinine market opportunities vary by end market size?
How does Artemisinine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Artemisinine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Artemisinine by Country/Region, 2019, 2023 & 2030
2.2 Artemisinine Segment by Type
2.2.1 Extraction from Artemisia annua
2.2.2 Semisynthetic Artemisinine
2.3 Artemisinine Sales by Type
2.3.1 Global Artemisinine Sales Market Share by Type (2019-2024)
2.3.2 Global Artemisinine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Artemisinine Sale Price by Type (2019-2024)
2.4 Artemisinine Segment by Application
2.4.1 Injections
2.4.2 Tablets
2.4.3 Others
2.5 Artemisinine Sales by Application
2.5.1 Global Artemisinine Sale Market Share by Application (2019-2024)
2.5.2 Global Artemisinine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Artemisinine Sale Price by Application (2019-2024)
3 GLOBAL ARTEMISININE BY COMPANY
3.1 Global Artemisinine Breakdown Data by Company
3.1.1 Global Artemisinine Annual Sales by Company (2019-2024)
3.1.2 Global Artemisinine Sales Market Share by Company (2019-2024)
3.2 Global Artemisinine Annual Revenue by Company (2019-2024)
3.2.1 Global Artemisinine Revenue by Company (2019-2024)
3.2.2 Global Artemisinine Revenue Market Share by Company (2019-2024)
3.3 Global Artemisinine Sale Price by Company
3.4 Key Manufacturers Artemisinine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinine Product Location Distribution
3.4.2 Players Artemisinine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTEMISININE BY GEOGRAPHIC REGION
4.1 World Historic Artemisinine Market Size by Geographic Region (2019-2024)
4.1.1 Global Artemisinine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Artemisinine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Artemisinine Market Size by Country/Region (2019-2024)
4.2.1 Global Artemisinine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Artemisinine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artemisinine Sales Growth
4.4 APAC Artemisinine Sales Growth
4.5 Europe Artemisinine Sales Growth
4.6 Middle East & Africa Artemisinine Sales Growth
5 AMERICAS
5.1 Americas Artemisinine Sales by Country
5.1.1 Americas Artemisinine Sales by Country (2019-2024)
5.1.2 Americas Artemisinine Revenue by Country (2019-2024)
5.2 Americas Artemisinine Sales by Type
5.3 Americas Artemisinine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinine Sales by Region
6.1.1 APAC Artemisinine Sales by Region (2019-2024)
6.1.2 APAC Artemisinine Revenue by Region (2019-2024)
6.2 APAC Artemisinine Sales by Type
6.3 APAC Artemisinine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinine by Country
7.1.1 Europe Artemisinine Sales by Country (2019-2024)
7.1.2 Europe Artemisinine Revenue by Country (2019-2024)
7.2 Europe Artemisinine Sales by Type
7.3 Europe Artemisinine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinine by Country
8.1.1 Middle East & Africa Artemisinine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Artemisinine Revenue by Country (2019-2024)
8.2 Middle East & Africa Artemisinine Sales by Type
8.3 Middle East & Africa Artemisinine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinine
10.3 Manufacturing Process Analysis of Artemisinine
10.4 Industry Chain Structure of Artemisinine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinine Distributors
11.3 Artemisinine Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININE BY GEOGRAPHIC REGION
12.1 Global Artemisinine Market Size Forecast by Region
12.1.1 Global Artemisinine Forecast by Region (2025-2030)
12.1.2 Global Artemisinine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinine Forecast by Type
12.7 Global Artemisinine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Guilin Pharmaceutical
13.1.1 Guilin Pharmaceutical Company Information
13.1.2 Guilin Pharmaceutical Artemisinine Product Portfolios and Specifications
13.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Guilin Pharmaceutical Main Business Overview
13.1.5 Guilin Pharmaceutical Latest Developments
13.2 CAT KHANH
13.2.1 CAT KHANH Company Information
13.2.2 CAT KHANH Artemisinine Product Portfolios and Specifications
13.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CAT KHANH Main Business Overview
13.2.5 CAT KHANH Latest Developments
13.3 Novanat Bioresource
13.3.1 Novanat Bioresource Company Information
13.3.2 Novanat Bioresource Artemisinine Product Portfolios and Specifications
13.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novanat Bioresource Main Business Overview
13.3.5 Novanat Bioresource Latest Developments
13.4 BEEPZ
13.4.1 BEEPZ Company Information
13.4.2 BEEPZ Artemisinine Product Portfolios and Specifications
13.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BEEPZ Main Business Overview
13.4.5 BEEPZ Latest Developments
13.5 KPC Pharmaceuticals
13.5.1 KPC Pharmaceuticals Company Information
13.5.2 KPC Pharmaceuticals Artemisinine Product Portfolios and Specifications
13.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 KPC Pharmaceuticals Main Business Overview
13.5.5 KPC Pharmaceuticals Latest Developments
13.6 BIONEXX
13.6.1 BIONEXX Company Information
13.6.2 BIONEXX Artemisinine Product Portfolios and Specifications
13.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BIONEXX Main Business Overview
13.6.5 BIONEXX Latest Developments
13.7 Guangxi xiancaotang
13.7.1 Guangxi xiancaotang Company Information
13.7.2 Guangxi xiancaotang Artemisinine Product Portfolios and Specifications
13.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Guangxi xiancaotang Main Business Overview
13.7.5 Guangxi xiancaotang Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Artemisinine Product Portfolios and Specifications
13.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Natural Bio-engineering
13.9.1 Natural Bio-engineering Company Information
13.9.2 Natural Bio-engineering Artemisinine Product Portfolios and Specifications
13.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Natural Bio-engineering Main Business Overview
13.9.5 Natural Bio-engineering Latest Developments
13.10 Kerui nanhai
13.10.1 Kerui nanhai Company Information
13.10.2 Kerui nanhai Artemisinine Product Portfolios and Specifications
13.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Kerui nanhai Main Business Overview
13.10.5 Kerui nanhai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Artemisinine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Artemisinine by Country/Region, 2019, 2023 & 2030
2.2 Artemisinine Segment by Type
2.2.1 Extraction from Artemisia annua
2.2.2 Semisynthetic Artemisinine
2.3 Artemisinine Sales by Type
2.3.1 Global Artemisinine Sales Market Share by Type (2019-2024)
2.3.2 Global Artemisinine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Artemisinine Sale Price by Type (2019-2024)
2.4 Artemisinine Segment by Application
2.4.1 Injections
2.4.2 Tablets
2.4.3 Others
2.5 Artemisinine Sales by Application
2.5.1 Global Artemisinine Sale Market Share by Application (2019-2024)
2.5.2 Global Artemisinine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Artemisinine Sale Price by Application (2019-2024)
3 GLOBAL ARTEMISININE BY COMPANY
3.1 Global Artemisinine Breakdown Data by Company
3.1.1 Global Artemisinine Annual Sales by Company (2019-2024)
3.1.2 Global Artemisinine Sales Market Share by Company (2019-2024)
3.2 Global Artemisinine Annual Revenue by Company (2019-2024)
3.2.1 Global Artemisinine Revenue by Company (2019-2024)
3.2.2 Global Artemisinine Revenue Market Share by Company (2019-2024)
3.3 Global Artemisinine Sale Price by Company
3.4 Key Manufacturers Artemisinine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Artemisinine Product Location Distribution
3.4.2 Players Artemisinine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ARTEMISININE BY GEOGRAPHIC REGION
4.1 World Historic Artemisinine Market Size by Geographic Region (2019-2024)
4.1.1 Global Artemisinine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Artemisinine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Artemisinine Market Size by Country/Region (2019-2024)
4.2.1 Global Artemisinine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Artemisinine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artemisinine Sales Growth
4.4 APAC Artemisinine Sales Growth
4.5 Europe Artemisinine Sales Growth
4.6 Middle East & Africa Artemisinine Sales Growth
5 AMERICAS
5.1 Americas Artemisinine Sales by Country
5.1.1 Americas Artemisinine Sales by Country (2019-2024)
5.1.2 Americas Artemisinine Revenue by Country (2019-2024)
5.2 Americas Artemisinine Sales by Type
5.3 Americas Artemisinine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinine Sales by Region
6.1.1 APAC Artemisinine Sales by Region (2019-2024)
6.1.2 APAC Artemisinine Revenue by Region (2019-2024)
6.2 APAC Artemisinine Sales by Type
6.3 APAC Artemisinine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Artemisinine by Country
7.1.1 Europe Artemisinine Sales by Country (2019-2024)
7.1.2 Europe Artemisinine Revenue by Country (2019-2024)
7.2 Europe Artemisinine Sales by Type
7.3 Europe Artemisinine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinine by Country
8.1.1 Middle East & Africa Artemisinine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Artemisinine Revenue by Country (2019-2024)
8.2 Middle East & Africa Artemisinine Sales by Type
8.3 Middle East & Africa Artemisinine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Artemisinine
10.3 Manufacturing Process Analysis of Artemisinine
10.4 Industry Chain Structure of Artemisinine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Artemisinine Distributors
11.3 Artemisinine Customer
12 WORLD FORECAST REVIEW FOR ARTEMISININE BY GEOGRAPHIC REGION
12.1 Global Artemisinine Market Size Forecast by Region
12.1.1 Global Artemisinine Forecast by Region (2025-2030)
12.1.2 Global Artemisinine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Artemisinine Forecast by Type
12.7 Global Artemisinine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Guilin Pharmaceutical
13.1.1 Guilin Pharmaceutical Company Information
13.1.2 Guilin Pharmaceutical Artemisinine Product Portfolios and Specifications
13.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Guilin Pharmaceutical Main Business Overview
13.1.5 Guilin Pharmaceutical Latest Developments
13.2 CAT KHANH
13.2.1 CAT KHANH Company Information
13.2.2 CAT KHANH Artemisinine Product Portfolios and Specifications
13.2.3 CAT KHANH Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 CAT KHANH Main Business Overview
13.2.5 CAT KHANH Latest Developments
13.3 Novanat Bioresource
13.3.1 Novanat Bioresource Company Information
13.3.2 Novanat Bioresource Artemisinine Product Portfolios and Specifications
13.3.3 Novanat Bioresource Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novanat Bioresource Main Business Overview
13.3.5 Novanat Bioresource Latest Developments
13.4 BEEPZ
13.4.1 BEEPZ Company Information
13.4.2 BEEPZ Artemisinine Product Portfolios and Specifications
13.4.3 BEEPZ Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BEEPZ Main Business Overview
13.4.5 BEEPZ Latest Developments
13.5 KPC Pharmaceuticals
13.5.1 KPC Pharmaceuticals Company Information
13.5.2 KPC Pharmaceuticals Artemisinine Product Portfolios and Specifications
13.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 KPC Pharmaceuticals Main Business Overview
13.5.5 KPC Pharmaceuticals Latest Developments
13.6 BIONEXX
13.6.1 BIONEXX Company Information
13.6.2 BIONEXX Artemisinine Product Portfolios and Specifications
13.6.3 BIONEXX Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 BIONEXX Main Business Overview
13.6.5 BIONEXX Latest Developments
13.7 Guangxi xiancaotang
13.7.1 Guangxi xiancaotang Company Information
13.7.2 Guangxi xiancaotang Artemisinine Product Portfolios and Specifications
13.7.3 Guangxi xiancaotang Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Guangxi xiancaotang Main Business Overview
13.7.5 Guangxi xiancaotang Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Artemisinine Product Portfolios and Specifications
13.8.3 Sanofi Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Natural Bio-engineering
13.9.1 Natural Bio-engineering Company Information
13.9.2 Natural Bio-engineering Artemisinine Product Portfolios and Specifications
13.9.3 Natural Bio-engineering Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Natural Bio-engineering Main Business Overview
13.9.5 Natural Bio-engineering Latest Developments
13.10 Kerui nanhai
13.10.1 Kerui nanhai Company Information
13.10.2 Kerui nanhai Artemisinine Product Portfolios and Specifications
13.10.3 Kerui nanhai Artemisinine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Kerui nanhai Main Business Overview
13.10.5 Kerui nanhai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artemisinine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Artemisinine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Extraction from Artemisia annua
Table 4. Major Players of Semisynthetic Artemisinine
Table 5. Global Artemisinine Sales by Type (2019-2024) & (K Units)
Table 6. Global Artemisinine Sales Market Share by Type (2019-2024)
Table 7. Global Artemisinine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Artemisinine Revenue Market Share by Type (2019-2024)
Table 9. Global Artemisinine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Artemisinine Sales by Application (2019-2024) & (K Units)
Table 11. Global Artemisinine Sales Market Share by Application (2019-2024)
Table 12. Global Artemisinine Revenue by Application (2019-2024)
Table 13. Global Artemisinine Revenue Market Share by Application (2019-2024)
Table 14. Global Artemisinine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Artemisinine Sales by Company (2019-2024) & (K Units)
Table 16. Global Artemisinine Sales Market Share by Company (2019-2024)
Table 17. Global Artemisinine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Artemisinine Revenue Market Share by Company (2019-2024)
Table 19. Global Artemisinine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Artemisinine Producing Area Distribution and Sales Area
Table 21. Players Artemisinine Products Offered
Table 22. Artemisinine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Artemisinine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Artemisinine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Artemisinine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Artemisinine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Artemisinine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Artemisinine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Artemisinine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Artemisinine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Artemisinine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Artemisinine Sales Market Share by Country (2019-2024)
Table 35. Americas Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Artemisinine Revenue Market Share by Country (2019-2024)
Table 37. Americas Artemisinine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Artemisinine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Artemisinine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Artemisinine Sales Market Share by Region (2019-2024)
Table 41. APAC Artemisinine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Artemisinine Revenue Market Share by Region (2019-2024)
Table 43. APAC Artemisinine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Artemisinine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Artemisinine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Artemisinine Sales Market Share by Country (2019-2024)
Table 47. Europe Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Artemisinine Revenue Market Share by Country (2019-2024)
Table 49. Europe Artemisinine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Artemisinine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Artemisinine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Artemisinine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Artemisinine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Artemisinine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Artemisinine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Artemisinine
Table 58. Key Market Challenges & Risks of Artemisinine
Table 59. Key Industry Trends of Artemisinine
Table 60. Artemisinine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Artemisinine Distributors List
Table 63. Artemisinine Customer List
Table 64. Global Artemisinine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Artemisinine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Artemisinine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Artemisinine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Artemisinine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Artemisinine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Artemisinine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Artemisinine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Guilin Pharmaceutical Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 79. Guilin Pharmaceutical Artemisinine Product Portfolios and Specifications
Table 80. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Guilin Pharmaceutical Main Business
Table 82. Guilin Pharmaceutical Latest Developments
Table 83. CAT KHANH Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 84. CAT KHANH Artemisinine Product Portfolios and Specifications
Table 85. CAT KHANH Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. CAT KHANH Main Business
Table 87. CAT KHANH Latest Developments
Table 88. Novanat Bioresource Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novanat Bioresource Artemisinine Product Portfolios and Specifications
Table 90. Novanat Bioresource Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novanat Bioresource Main Business
Table 92. Novanat Bioresource Latest Developments
Table 93. BEEPZ Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 94. BEEPZ Artemisinine Product Portfolios and Specifications
Table 95. BEEPZ Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. BEEPZ Main Business
Table 97. BEEPZ Latest Developments
Table 98. KPC Pharmaceuticals Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 99. KPC Pharmaceuticals Artemisinine Product Portfolios and Specifications
Table 100. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. KPC Pharmaceuticals Main Business
Table 102. KPC Pharmaceuticals Latest Developments
Table 103. BIONEXX Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 104. BIONEXX Artemisinine Product Portfolios and Specifications
Table 105. BIONEXX Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. BIONEXX Main Business
Table 107. BIONEXX Latest Developments
Table 108. Guangxi xiancaotang Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangxi xiancaotang Artemisinine Product Portfolios and Specifications
Table 110. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Guangxi xiancaotang Main Business
Table 112. Guangxi xiancaotang Latest Developments
Table 113. Sanofi Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sanofi Artemisinine Product Portfolios and Specifications
Table 115. Sanofi Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Sanofi Main Business
Table 117. Sanofi Latest Developments
Table 118. Natural Bio-engineering Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 119. Natural Bio-engineering Artemisinine Product Portfolios and Specifications
Table 120. Natural Bio-engineering Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Natural Bio-engineering Main Business
Table 122. Natural Bio-engineering Latest Developments
Table 123. Kerui nanhai Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 124. Kerui nanhai Artemisinine Product Portfolios and Specifications
Table 125. Kerui nanhai Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Kerui nanhai Main Business
Table 127. Kerui nanhai Latest Developments
Table 1. Artemisinine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Artemisinine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Extraction from Artemisia annua
Table 4. Major Players of Semisynthetic Artemisinine
Table 5. Global Artemisinine Sales by Type (2019-2024) & (K Units)
Table 6. Global Artemisinine Sales Market Share by Type (2019-2024)
Table 7. Global Artemisinine Revenue by Type (2019-2024) & ($ million)
Table 8. Global Artemisinine Revenue Market Share by Type (2019-2024)
Table 9. Global Artemisinine Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global Artemisinine Sales by Application (2019-2024) & (K Units)
Table 11. Global Artemisinine Sales Market Share by Application (2019-2024)
Table 12. Global Artemisinine Revenue by Application (2019-2024)
Table 13. Global Artemisinine Revenue Market Share by Application (2019-2024)
Table 14. Global Artemisinine Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global Artemisinine Sales by Company (2019-2024) & (K Units)
Table 16. Global Artemisinine Sales Market Share by Company (2019-2024)
Table 17. Global Artemisinine Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Artemisinine Revenue Market Share by Company (2019-2024)
Table 19. Global Artemisinine Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers Artemisinine Producing Area Distribution and Sales Area
Table 21. Players Artemisinine Products Offered
Table 22. Artemisinine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Artemisinine Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Artemisinine Sales Market Share Geographic Region (2019-2024)
Table 27. Global Artemisinine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Artemisinine Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Artemisinine Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Artemisinine Sales Market Share by Country/Region (2019-2024)
Table 31. Global Artemisinine Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Artemisinine Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Artemisinine Sales by Country (2019-2024) & (K Units)
Table 34. Americas Artemisinine Sales Market Share by Country (2019-2024)
Table 35. Americas Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Artemisinine Revenue Market Share by Country (2019-2024)
Table 37. Americas Artemisinine Sales by Type (2019-2024) & (K Units)
Table 38. Americas Artemisinine Sales by Application (2019-2024) & (K Units)
Table 39. APAC Artemisinine Sales by Region (2019-2024) & (K Units)
Table 40. APAC Artemisinine Sales Market Share by Region (2019-2024)
Table 41. APAC Artemisinine Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Artemisinine Revenue Market Share by Region (2019-2024)
Table 43. APAC Artemisinine Sales by Type (2019-2024) & (K Units)
Table 44. APAC Artemisinine Sales by Application (2019-2024) & (K Units)
Table 45. Europe Artemisinine Sales by Country (2019-2024) & (K Units)
Table 46. Europe Artemisinine Sales Market Share by Country (2019-2024)
Table 47. Europe Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Artemisinine Revenue Market Share by Country (2019-2024)
Table 49. Europe Artemisinine Sales by Type (2019-2024) & (K Units)
Table 50. Europe Artemisinine Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Artemisinine Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Artemisinine Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Artemisinine Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Artemisinine Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Artemisinine Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Artemisinine Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Artemisinine
Table 58. Key Market Challenges & Risks of Artemisinine
Table 59. Key Industry Trends of Artemisinine
Table 60. Artemisinine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Artemisinine Distributors List
Table 63. Artemisinine Customer List
Table 64. Global Artemisinine Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Artemisinine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Artemisinine Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Artemisinine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Artemisinine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Artemisinine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Artemisinine Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Artemisinine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Artemisinine Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Artemisinine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Guilin Pharmaceutical Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 79. Guilin Pharmaceutical Artemisinine Product Portfolios and Specifications
Table 80. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Guilin Pharmaceutical Main Business
Table 82. Guilin Pharmaceutical Latest Developments
Table 83. CAT KHANH Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 84. CAT KHANH Artemisinine Product Portfolios and Specifications
Table 85. CAT KHANH Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. CAT KHANH Main Business
Table 87. CAT KHANH Latest Developments
Table 88. Novanat Bioresource Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 89. Novanat Bioresource Artemisinine Product Portfolios and Specifications
Table 90. Novanat Bioresource Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Novanat Bioresource Main Business
Table 92. Novanat Bioresource Latest Developments
Table 93. BEEPZ Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 94. BEEPZ Artemisinine Product Portfolios and Specifications
Table 95. BEEPZ Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. BEEPZ Main Business
Table 97. BEEPZ Latest Developments
Table 98. KPC Pharmaceuticals Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 99. KPC Pharmaceuticals Artemisinine Product Portfolios and Specifications
Table 100. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. KPC Pharmaceuticals Main Business
Table 102. KPC Pharmaceuticals Latest Developments
Table 103. BIONEXX Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 104. BIONEXX Artemisinine Product Portfolios and Specifications
Table 105. BIONEXX Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. BIONEXX Main Business
Table 107. BIONEXX Latest Developments
Table 108. Guangxi xiancaotang Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangxi xiancaotang Artemisinine Product Portfolios and Specifications
Table 110. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Guangxi xiancaotang Main Business
Table 112. Guangxi xiancaotang Latest Developments
Table 113. Sanofi Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sanofi Artemisinine Product Portfolios and Specifications
Table 115. Sanofi Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Sanofi Main Business
Table 117. Sanofi Latest Developments
Table 118. Natural Bio-engineering Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 119. Natural Bio-engineering Artemisinine Product Portfolios and Specifications
Table 120. Natural Bio-engineering Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Natural Bio-engineering Main Business
Table 122. Natural Bio-engineering Latest Developments
Table 123. Kerui nanhai Basic Information, Artemisinine Manufacturing Base, Sales Area and Its Competitors
Table 124. Kerui nanhai Artemisinine Product Portfolios and Specifications
Table 125. Kerui nanhai Artemisinine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Kerui nanhai Main Business
Table 127. Kerui nanhai Latest Developments
LIST OF FIGURES
Figure 1. Picture of Artemisinine
Figure 2. Artemisinine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Artemisinine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Artemisinine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Extraction from Artemisia annua
Figure 10. Product Picture of Semisynthetic Artemisinine
Figure 11. Global Artemisinine Sales Market Share by Type in 2023
Figure 12. Global Artemisinine Revenue Market Share by Type (2019-2024)
Figure 13. Artemisinine Consumed in Injections
Figure 14. Global Artemisinine Market: Injections (2019-2024) & (K Units)
Figure 15. Artemisinine Consumed in Tablets
Figure 16. Global Artemisinine Market: Tablets (2019-2024) & (K Units)
Figure 17. Artemisinine Consumed in Others
Figure 18. Global Artemisinine Market: Others (2019-2024) & (K Units)
Figure 19. Global Artemisinine Sales Market Share by Application (2023)
Figure 20. Global Artemisinine Revenue Market Share by Application in 2023
Figure 21. Artemisinine Sales Market by Company in 2023 (K Units)
Figure 22. Global Artemisinine Sales Market Share by Company in 2023
Figure 23. Artemisinine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Artemisinine Revenue Market Share by Company in 2023
Figure 25. Global Artemisinine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Artemisinine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Artemisinine Sales 2019-2024 (K Units)
Figure 28. Americas Artemisinine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Artemisinine Sales 2019-2024 (K Units)
Figure 30. APAC Artemisinine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Artemisinine Sales 2019-2024 (K Units)
Figure 32. Europe Artemisinine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Artemisinine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Artemisinine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Artemisinine Sales Market Share by Country in 2023
Figure 36. Americas Artemisinine Revenue Market Share by Country in 2023
Figure 37. Americas Artemisinine Sales Market Share by Type (2019-2024)
Figure 38. Americas Artemisinine Sales Market Share by Application (2019-2024)
Figure 39. United States Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Artemisinine Sales Market Share by Region in 2023
Figure 44. APAC Artemisinine Revenue Market Share by Regions in 2023
Figure 45. APAC Artemisinine Sales Market Share by Type (2019-2024)
Figure 46. APAC Artemisinine Sales Market Share by Application (2019-2024)
Figure 47. China Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Artemisinine Sales Market Share by Country in 2023
Figure 55. Europe Artemisinine Revenue Market Share by Country in 2023
Figure 56. Europe Artemisinine Sales Market Share by Type (2019-2024)
Figure 57. Europe Artemisinine Sales Market Share by Application (2019-2024)
Figure 58. Germany Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Artemisinine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Artemisinine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Artemisinine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Artemisinine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Artemisinine in 2023
Figure 73. Manufacturing Process Analysis of Artemisinine
Figure 74. Industry Chain Structure of Artemisinine
Figure 75. Channels of Distribution
Figure 76. Global Artemisinine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Artemisinine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Artemisinine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Artemisinine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Artemisinine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Artemisinine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Artemisinine
Figure 2. Artemisinine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Artemisinine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Artemisinine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Artemisinine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Extraction from Artemisia annua
Figure 10. Product Picture of Semisynthetic Artemisinine
Figure 11. Global Artemisinine Sales Market Share by Type in 2023
Figure 12. Global Artemisinine Revenue Market Share by Type (2019-2024)
Figure 13. Artemisinine Consumed in Injections
Figure 14. Global Artemisinine Market: Injections (2019-2024) & (K Units)
Figure 15. Artemisinine Consumed in Tablets
Figure 16. Global Artemisinine Market: Tablets (2019-2024) & (K Units)
Figure 17. Artemisinine Consumed in Others
Figure 18. Global Artemisinine Market: Others (2019-2024) & (K Units)
Figure 19. Global Artemisinine Sales Market Share by Application (2023)
Figure 20. Global Artemisinine Revenue Market Share by Application in 2023
Figure 21. Artemisinine Sales Market by Company in 2023 (K Units)
Figure 22. Global Artemisinine Sales Market Share by Company in 2023
Figure 23. Artemisinine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Artemisinine Revenue Market Share by Company in 2023
Figure 25. Global Artemisinine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Artemisinine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Artemisinine Sales 2019-2024 (K Units)
Figure 28. Americas Artemisinine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Artemisinine Sales 2019-2024 (K Units)
Figure 30. APAC Artemisinine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Artemisinine Sales 2019-2024 (K Units)
Figure 32. Europe Artemisinine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Artemisinine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Artemisinine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Artemisinine Sales Market Share by Country in 2023
Figure 36. Americas Artemisinine Revenue Market Share by Country in 2023
Figure 37. Americas Artemisinine Sales Market Share by Type (2019-2024)
Figure 38. Americas Artemisinine Sales Market Share by Application (2019-2024)
Figure 39. United States Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Artemisinine Sales Market Share by Region in 2023
Figure 44. APAC Artemisinine Revenue Market Share by Regions in 2023
Figure 45. APAC Artemisinine Sales Market Share by Type (2019-2024)
Figure 46. APAC Artemisinine Sales Market Share by Application (2019-2024)
Figure 47. China Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Artemisinine Sales Market Share by Country in 2023
Figure 55. Europe Artemisinine Revenue Market Share by Country in 2023
Figure 56. Europe Artemisinine Sales Market Share by Type (2019-2024)
Figure 57. Europe Artemisinine Sales Market Share by Application (2019-2024)
Figure 58. Germany Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Artemisinine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Artemisinine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Artemisinine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Artemisinine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Artemisinine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Artemisinine in 2023
Figure 73. Manufacturing Process Analysis of Artemisinine
Figure 74. Industry Chain Structure of Artemisinine
Figure 75. Channels of Distribution
Figure 76. Global Artemisinine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Artemisinine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Artemisinine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Artemisinine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Artemisinine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Artemisinine Revenue Market Share Forecast by Application (2025-2030)
